Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...
iXCells Biotechnologies USA, Inc. ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果